Randomized phase II study of everolimus (E), leuprolide + letrozole (LL), and E + LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC)

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 33; no. 15_suppl; p. e15149
Main Authors Abou-Alfa, Ghassan K., Mayer, Robert J., Cosgrove, David, Capanu, Marinela, Choti, Michael A., Atreya, Chloe Evelyn, Ang, Celina, Kelley, Robin Kate, Do, Richard Kinh Gian, Gordan, John Dozier, Zhu, Andrew X., Ly, Michele, Nolan, Patrick, Lubin, Lakeisha, Harding, James J., Saltz, Leonard, Venook, Alan P.
Format Journal Article
LanguageEnglish
Published 20.05.2015
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2015.33.15_suppl.e15149